March 6, 2026

 

Norway-based Biosort gets funding for lice-removing technology targeted at salmon farming

 

 

Oslo, Norway-based aquaculture technology company Biosort has received kr100 million (US$10.4 million) from a group of investors to bring its new project focused on lice control to market.

 

The funding will be used to support the final development and market introduction of new technology that aims to remove lice from farmed salmon at an early stage, which the company said will help prevent uncontrolled lice population growth and reduce the need for wellboat interventions.

 

"This funding takes us from development into commercial sales," Biosort chief executive officer Geir Stang Hauge said. "Our focus is simple: continuous lice removal to suppress lice development and greatly reduce needs for wellboat treatments. The goal is improved welfare, lower mortality, better biological control, and ultimately making fish thrive." 

 

The company added that determining the exact biological situation playing out in farmed fish pens is essential to fish health and growth, and with technology allowing for a greater look into the process during farming, preventive actions like lice removal are possible.

 

The lice control technology will operate cohesively with Biosort's technology iFarm that identifies and tracks individual salmon, as the new technology will remove lice from salmon that iFarm has tracked and detected, according to a release by the company.

 

Alongside existing investors, the group of new investors on the project include Bergen, Norway-based aquaculture and technology investment companies Grieg Kapital, Farvatn, and Futurum Ventures; Cork, Ireland-based global aquaculture investment firm Hatch Blue; and Trondheim, Norway-based global aquaculture investment firm Ichthus Venture Capital (IVC).

 

"We have followed Biosort for several years and are impressed by the team and their technology," Grieg Kapital investment manager Stian Grieg said. "Sea lice remain one of the greatest challenges in salmon farming, and Biosort's approach has the potential to improve both lice management and fish health. We are excited to support the company as it moves into commercialisation."

 

Blue Hatch added in the release that there is a "clear shift" in the salmon industry toward focusing on fish health through new technology in a proactive manner. The company also said its Blue Revolution Fund allows it to invest in next-generation aquaculture solutions that help improve the health of farmed fish while promoting sustainability, including the new technology from Biosort.

 

"Together with a strong and experienced investor consortium, we believe Biosort is well-positioned to contribute to the next phase of salmon farming," Hatch Blue managing partner Carsten Krome said.

 

- SeafoodSource